world
made
awar
newli
discov
coronaviru
via
email
dr
ali
moham
zaki
egyptian
virologist
work
dr
soliman
fakeeh
hospit
jeddah
kingdom
saudi
arabia
ksa
email
publish
websit
profession
emerg
diseas
prome
network
prome
first
case
year
old
man
bisha
ksa
thank
email
rapid
discoveri
second
case
viru
time
ill
patient
qatar
transfer
unit
kingdom
care
fig
bermingham
et
al
januari
detect
viral
rna
virusspecif
antibodi
report
publicli
confirm
world
health
organ
third
posit
peopl
die
n
data
public
sourc
includ
ministri
health
first
known
novel
coronaviru
ncov
follow
two
three
year
slow
discoveri
process
reveal
viru
appear
well
establish
among
dromedari
camel
dc
camelu
dromedariu
across
arabian
peninsula
part
africa
infect
dc
viru
thought
infrequ
infect
expos
human
concern
rais
earli
patent
first
viral
isol
would
lead
restrict
access
viru
viral
diagnost
sciencemag
howev
sensit
valid
revers
transcriptas
realtim
polymeras
chain
reaction
rtrtpcr
base
diagnost
avail
abdelmoneim
almost
immedi
viru
also
made
freeli
avail
subject
routin
biosafeti
consider
support
mani
research
find
describ
herein
search
anim
host
bat
implic
august
month
dc
link
report
reusken
et
al
link
matur
verifi
associ
human
overt
diseas
final
given
name
middl
east
respiratori
syndrom
acronym
mer
animaltohuman
spillov
event
mer
coronaviru
merscov
see
section
variat
name
spread
sporad
among
peopl
caus
sever
diseas
among
older
male
underli
diseas
proport
infect
peopl
confirm
die
merscov
infect
much
higher
sever
acut
respiratori
syndrom
sar
cov
influenza
viru
mani
pathogen
spread
merscov
among
human
often
associ
outbreak
hospit
usual
commenc
march
mackay
maltez
tsiodra
spread
may
link
season
environment
chang
chang
host
anim
behaviour
perhap
simpl
coincid
season
success
hospit
outbreak
approxim
fifth
case
date
involv
healthcar
worker
hcw
spike
alongsid
period
increas
total
case
number
social
media
blog
mainstream
media
kept
close
tab
spread
merscov
countri
europ
asia
unit
state
america
usa
fig
mostli
origin
ksa
viral
detect
occur
twitter
particular
provid
global
forum
specif
hashtag
like
mer
arab
hashtag
coruna
engag
world
help
understand
viru
affect
ksa
neighbour
countri
allow
outsid
view
scienc
muse
take
shape
collabor
form
local
news
commentari
trend
new
result
discuss
real
time
social
media
provid
new
avenu
scientist
express
experienc
opinion
wide
commun
research
engag
public
health
entiti
public
mainstream
media
degre
engag
possibl
sar
global
outbreak
began
rise
human
case
includ
death
proport
fatal
case
pfc
ubiqu
social
media
appear
chang
public
expect
state
commun
new
exist
infecti
diseas
outbreak
epidem
quickli
expect
occur
patient
mer
often
present
hospit
system
lower
respiratori
tract
lrt
sign
symptom
diseas
usual
includ
fever
chill
rigor
dri
product
cough
short
breath
dyspnea
one
comorbid
includ
diabet
preval
ksa
chronic
kidney
diseas
includ
renal
failur
chronic
heart
diseas
heart
failur
recent
surgeri
hypertens
chronic
lung
diseas
asthma
obes
smoke
malign
diseas
steroid
use
arabi
et
al
assiri
et
al
hijawi
et
al
zaki
et
al
merscov
may
identifi
patient
sever
hypoxaem
respiratori
failur
extrapulmonari
organ
dysfunct
preced
death
third
infect
arabi
et
al
assiri
et
al
hijawi
et
al
zaki
et
al
extrapulmonari
diseas
manifest
includ
circulatori
renal
hepat
hematolog
dysfunct
gastrointestin
symptom
seen
case
assiri
et
al
maill
et
al
memish
et
al
zumla
memish
manifest
diarrhea
vomit
abdomin
pain
gastrointestin
symptom
seen
one
famili
cluster
omrani
et
al
among
symptomat
children
anoth
occas
fever
gastrointestin
upset
may
form
prodrom
symptom
declin
later
follow
sever
system
respiratori
sign
symptom
kraaijdirkzwag
et
al
maill
et
al
rare
merscov
detect
person
fever
respiratori
gastrointestin
symptom
extent
infect
gastrointestin
pathogen
affect
variabl
unknown
chest
radiographi
mer
patient
distinct
merscov
posit
peopl
subclin
infect
reveal
infiltr
consist
acut
viral
pneumonia
assiri
et
al
devi
et
al
tsiodra
et
al
zaki
et
al
rare
occas
studi
describ
upper
respiratori
tract
urt
sign
symptom
one
exampl
approxim
case
present
rhinorrhoea
andor
sore
throat
memish
et
al
payn
et
al
zumla
memish
date
mer
opportunist
diseas
sever
mer
defin
admiss
intens
care
unit
use
extracorpor
membran
oxygen
ecmo
mechan
ventil
vasopressor
case
report
critic
sever
fatal
outcom
arabi
et
al
rel
speed
diseas
progress
may
relat
merscov
reach
earlier
peak
viral
load
infect
differ
cell
sarscov
drosten
nonetheless
also
appar
mer
restrict
comorbid
increas
laboratori
test
particularli
contact
confirm
mer
case
number
merscov
posit
individu
without
comorbid
detect
experi
mild
ill
symptom
altawfiq
demonstr
mer
like
respiratori
virus
associ
wide
spectrum
symptom
degre
sever
mean
incub
period
studi
case
day
case
shown
symptom
within
day
assiri
et
al
smaller
studi
incub
period
rang
one
nine
day
day
ill
began
one
person
subsequ
spread
anoth
length
natur
prodrom
undefin
date
first
case
definit
world
health
organ
defin
probabl
case
mer
base
presenc
febril
ill
cough
requir
hospit
suspicion
lrt
involv
includ
role
contact
probabl
confirm
case
travel
resid
within
arabian
peninsula
strictli
adher
sever
syndrom
would
meet
case
definit
subject
laboratori
test
paradigm
earli
assiri
et
al
juli
revis
case
definit
includ
import
seek
understand
role
asymptomat
case
world
health
organ
apart
report
ksa
ministri
health
asymptomat
subclin
case
merscov
infect
also
document
scientif
literatur
memish
et
al
one
case
hcw
shed
viru
day
absenc
diseas
algethami
et
al
mer
progress
acut
respiratori
distress
syndrom
ard
requir
extern
ventil
multiorgan
failur
devi
et
al
reuss
et
al
zaki
et
al
similar
sever
influenza
sar
case
acut
renal
failur
occur
mer
patient
sooner
among
sar
patient
eckerl
et
al
progress
impair
renal
function
acut
kidney
injuri
start
day
symptom
onset
among
mer
patient
compar
median
day
sar
patient
chu
et
al
eckerl
et
al
zaki
et
al
may
due
direct
infect
renal
tissu
merscov
arabi
et
al
zaki
et
al
haematolog
chang
mer
case
includ
thrombocytopenia
assiri
et
al
drosten
et
al
omrani
et
al
lymphocytosi
assiri
et
al
lymphopenia
assiri
et
al
omrani
et
al
admiss
assiri
et
al
monocyt
number
often
normal
assiri
et
al
neutrophil
may
rais
normal
assiri
et
al
group
children
rare
report
posit
viru
septemb
decemb
paediatr
case
year
age
median
identifi
total
nine
asymptomat
one
die
amman
jordan
sampl
hospitalis
children
age
fever
andor
respiratori
sign
symptom
test
none
posit
merscov
rna
despit
collect
similar
time
first
known
outbreak
merscov
neighbour
town
alzarqa
khuribulo
et
al
second
trimest
stillbirth
occur
pregnant
woman
acut
respiratori
ill
rtrtpcr
posit
mother
subsequ
develop
antibodi
merscov
suggest
recent
infect
exposur
histori
merscov
rtrtpcr
posit
rel
antibodyreact
husband
incub
period
symptom
histori
met
criteria
probabl
merscov
case
viru
associ
mer
initi
identifi
novel
coronaviru
ncov
problemat
choic
given
novel
coronavirus
could
discov
discov
regular
prior
sinc
identif
merscov
first
genom
human
variant
sequenc
name
human
betacoronaviru
emc
subsequ
refer
implic
human
anim
coronaviru
also
variant
name
englandqatar
england
ten
month
discoveri
coronaviru
studi
group
assembl
intern
consensu
viru
renam
given
acronym
merscov
de
groot
et
al
merscov
put
member
new
speci
van
boheemen
et
al
within
order
nidoviral
famili
coronavirida
subfamili
coronavirina
genu
betacoronaviru
subgroup
raj
et
al
first
full
sequenc
defin
singlestrand
posit
sens
nucleotid
nt
long
genom
fig
van
boheemen
et
al
zaki
et
al
base
analysi
complet
sequenc
genom
predict
evolv
substitut
per
site
cotten
et
al
permit
predict
calcul
time
recent
viral
ancestor
tmrca
variant
suggest
merscov
first
appear
around
march
rang
decemb
juli
cotten
et
al
comparison
first
open
read
frame
orf
amino
acid
sequenc
closest
betacoronaviru
rel
tylonycteri
bat
pipistrellu
bat
found
less
ident
support
conclus
merscov
novel
distinct
viru
genom
region
key
taxonom
identifi
cov
speci
merscov
predict
encod
least
ten
open
read
frame
bracket
variant
isol
sputum
old
man
bisha
ksa
open
read
frame
indic
yellow
rectangl
bracket
termin
untransl
region
utr
grey
rectangl
utr
includ
predict
leader
l
transcriptionregulatori
sequenc
fsframeshift
predict
papainlik
proteinas
cleavag
site
indic
orang
arrow
result
cleavag
nonstructur
protein
product
base
van
boheemen
et
al
genom
drawn
scale
use
geneiou
annot
use
adob
illustr
merscov
sequenc
genbank
access
number
untransl
region
raj
et
al
structur
protein
includ
spike
envelop
e
membran
nucleocapsid
n
van
boheemen
et
al
nonstructur
protein
nsp
product
predict
follow
identif
conserv
domain
compar
analysi
coronavir
protein
nsp
includ
papainlik
proteas
plpro
kilianski
et
al
lin
et
al
transmembran
domain
proteas
kilianski
et
al
rnadepend
rna
polymeras
rdrp
helicas
exonucleas
van
boheemen
et
al
complet
genom
deduct
use
deep
sequenc
method
predomin
tool
genom
analysi
emerg
merscov
cotten
et
al
cotten
et
al
b
first
time
use
pervas
studi
viral
outbreak
global
reach
error
rate
higher
tradit
sanger
sequenc
nearcomplet
genom
length
cover
singl
run
eg
merscov
genom
depth
coverag
nucleotid
deep
sequenc
correct
erron
nucleotid
van
boheemen
et
al
subgenom
sequenc
mainstay
viral
genotyp
molecular
epidemiolog
point
use
rare
merscov
identif
confirm
despit
assay
suggest
earli
corman
et
al
approach
simpler
access
wider
rang
laboratori
faster
util
sinc
demonstr
use
molecular
assay
amplifi
sequenc
nucleotid
long
fragment
spike
domain
gene
fragment
smit
et
al
assay
agre
result
gener
sequenc
full
genom
defin
addit
sequenc
group
within
exist
merscov
clade
addit
genom
time
human
dc
two
clade
becom
appar
b
clade
contain
humanderiv
merscov
genom
fig
date
merscov
genom
collect
sampl
span
two
year
genet
similar
align
complet
nearcomplet
merscov
genom
sampl
differ
comparison
align
complet
genom
sampl
collect
show
diverg
nucleotid
level
data
shown
theoret
equat
genom
yet
studi
attach
clinic
relev
clade
smaller
group
merscov
genom
variat
note
date
interest
clade
contain
african
green
monkey
kidney
vero
innat
immun
defici
cell
cellcultur
passag
variant
two
variant
variant
camelderiv
merscov
genom
merscov
genom
variant
bisha
resequenc
directli
origin
urt
sampl
comparison
trim
genom
vs
bisha
reveal
nucleotid
differ
differ
resolv
bisha
clade
b
unusu
viru
intent
serial
pass
vero
cell
cultur
chang
occur
within
entir
code
region
result
sequenc
despit
eight
passag
frey
et
al
comparison
three
passag
vero
cell
cultur
genet
chang
found
dc
merscov
variant
qatar
diverg
merscov
variant
origin
egyptian
dc
like
import
sudan
identifi
construct
lineag
outsid
current
clade
perhap
compris
first
occup
clade
c
cotten
et
al
smit
et
al
lineag
may
repres
addit
divers
merscov
variant
remain
discov
dc
outsid
arabian
peninsula
viru
sequenc
neoromicia
capensi
bat
close
relat
merscov
previou
bat
sequenc
provid
link
human
camel
bat
virus
member
cov
speci
despit
usual
compris
total
genom
silico
comparison
show
viral
genet
chang
among
variant
permit
geograph
track
spread
variant
identif
riyadh
particular
harbour
wide
rang
merscov
variant
fig
process
molecular
epidemiolog
also
impli
physic
direct
movement
merscov
around
region
time
cotten
et
al
compar
bisha
singl
nucleotid
differ
among
variant
locat
last
third
genom
encompass
protein
fig
accessori
protein
least
nine
merscov
genom
harbour
amino
acid
substitut
ribosom
bind
domain
rbd
spike
protein
codon
ntermin
region
rbd
heptad
repeat
bear
investig
marker
adapt
chang
cotten
et
al
raj
et
al
studi
need
determin
whether
function
outcom
viru
replic
transmiss
due
futur
chang
cotten
et
al
earli
vitro
analysi
find
differ
shed
replic
immun
escap
among
virus
isol
may
locat
crystal
structur
rbd
describ
sever
report
du
et
al
lu
et
al
mou
et
al
wang
et
al
earli
diagnost
method
appear
within
day
prome
email
announc
first
mer
case
includ
vero
cell
cultur
sever
inhous
rtrtpcr
assay
fig
corman
et
al
b
zaki
et
al
antibodi
test
human
sera
remain
rare
rtrtpcr
assay
valid
corman
et
al
quickli
recommend
shown
sensit
genet
relationship
nearcomplet
complet
merscov
genom
nucleotid
sequenc
download
genbank
use
list
access
number
obtain
http
wwwhpaorguktopicsinfectiousdiseasesinfectionsazmerscovresppartialgeneticsequenceofnovelcoronaviru
neighbour
join
tree
creat
mega
use
align
human
dcderiv
merscov
sequenc
geneiou
tree
root
use
camel
clade
indic
next
dark
clade
pale
clade
b
blue
vertic
bar
camel
icon
denot
genom
dc
merscov
sequenc
describ
origin
patient
either
bisha
passag
cell
cultur
star
red
ident
genom
human
one
ill
camel
jeddah
azhar
et
al
ksa
also
star
yellow
healthcar
commun
outbreak
box
blue
green
pink
label
specif
corman
et
al
b
target
sequenc
recommend
screen
assay
remain
conserv
among
genom
least
last
check
imm
fig
rtrtpcr
upstream
e
region
upe
fig
schemat
depict
locat
primer
blue
arrow
indic
direct
oligoprob
green
rectangl
earliest
rtrtpcr
screen
assay
convent
seminest
three
primer
rtpcr
confirmatori
sequenc
assay
corman
et
al
b
perform
hajj
case
identifi
memish
et
al
may
reflect
absenc
merscov
lrt
test
memish
et
al
pilgrim
arriv
countri
without
known
merscov
circul
similarli
merscov
identifi
hajj
among
nasal
swab
pilgrim
test
rtrtpcr
corman
et
al
leav
depart
ksa
swab
pilgrim
influenzalik
ill
ksa
hajj
barashe
et
al
gautret
et
al
across
period
rapid
case
accumul
intens
screen
jeddah
march
juli
call
outbreak
hereaft
sampl
test
month
yield
merscov
detect
preval
mer
among
individu
sampl
test
across
ksa
octob
septemb
detect
made
use
upe
orf
assay
hospitalcentr
popul
includ
hospitalis
case
n
famili
n
associ
hcw
n
among
detect
hcw
famili
contact
time
high
merscov
activ
preval
differ
hospitalbas
preval
hcov
mackay
et
al
given
proport
death
among
infect
merscov
viru
reason
describ
storm
teacup
howev
date
given
mani
opportun
worldwid
spread
yet
taken
data
shown
one
rtrtpcr
neg
urt
sampl
clinic
suspect
mer
case
may
contradict
urt
sampl
prefer
use
lrt
sampl
bermingham
et
al
omrani
et
al
higher
viral
load
occur
lrt
compar
urt
especi
increas
time
onset
symptom
cdc
drosten
et
al
memish
et
al
sinc
major
diseas
symptom
appear
manifest
system
lrt
diseas
may
surpris
assiri
et
al
howev
write
human
data
exist
defin
whether
viru
replic
sole
lrt
urt
prefer
one
replic
human
tissu
vivo
sampl
urt
frequent
note
largest
human
merscov
investig
studi
gautret
et
al
health
protect
agenc
hpa
uk
novel
coronaviru
investig
team
memish
et
al
note
smaller
investig
merscov
test
kraaijdirkzwag
et
al
memish
et
al
macaqu
monkey
model
merscov
rna
shed
urt
lrt
dewit
et
al
human
case
throat
swab
posit
six
day
gap
kraaijdirkzwag
et
al
anoth
case
old
femal
hcw
shed
merscov
rna
urt
ziad
memish
person
commun
least
april
june
algethami
et
al
show
sign
diseas
time
shed
viru
studi
mer
case
intens
care
set
three
patient
shed
viru
day
arabi
et
al
elsewher
viral
rna
detect
human
oronas
swab
day
pharyng
endotrach
aspir
day
three
quarter
mer
case
shed
viral
rna
lower
respiratori
tract
specimen
tracheal
aspir
sputum
least
day
contact
still
shed
rna
upper
respiratori
specimen
memish
et
al
lrt
whorecommend
sampl
site
merscov
rtrtpcr
test
especi
collect
sampl
delay
week
symptom
onset
world
health
organ
sampl
test
includ
bronchoalveolar
lavag
bal
trachealtracheobronchi
aspir
pleural
fluid
sputum
cdc
world
health
organ
fresh
sampl
yield
better
diagnost
result
refriger
materi
delay
h
like
sampl
except
blood
frozen
c
cdc
lung
biopsi
autopsi
tissu
also
test
avail
world
health
organ
urt
less
invas
conveni
sampl
site
combin
nose
throat
swab
nasopharyng
aspir
recommend
cdc
pair
sera
collect
two
three
week
apart
prefer
serolog
test
singl
sampl
prefer
collect
two
week
onset
diseas
world
health
organ
urin
found
contain
merscov
rna
day
symptom
onset
stool
sampl
rtrtpcr
posit
day
onset
kraaijdirkzwag
et
al
sampl
type
consid
cdc
world
health
organ
two
case
arriv
netherland
urin
rtrtpcr
neg
faec
weakli
posit
sera
rtrtpcr
posit
five
day
kraaijdirkzwag
et
al
merscov
viral
rna
detect
serum
proven
use
retrospect
sourc
pcr
templat
respiratori
sampl
avail
hijawi
et
al
rnaaemia
may
also
correl
diseas
sever
sign
viru
clear
serum
one
recov
human
case
linger
death
anoth
faur
et
al
studi
differ
sampl
type
nasopharyng
npa
tracheal
aspir
sputa
bal
tracheal
aspir
bal
return
best
viral
load
valu
follow
npa
sputum
gener
equat
whole
genom
sequenc
success
memish
et
al
repres
studi
effect
sampl
type
molecular
analysi
confirm
import
lrt
sampl
whole
genom
sequenc
note
sampl
distinct
patient
ksa
fact
origin
urt
memish
et
al
mani
studi
make
mention
addit
test
endem
human
respiratori
virus
bacteria
assiri
et
al
b
devi
et
al
virus
sought
includ
follow
human
herpesviru
hhv
rhinoviru
hrv
enteroviru
ev
respiratori
syncyti
viru
rsv
parainfluenzaviru
type
piv
influenzavirus
ifv
endem
hcov
adenovirus
adv
metapneumoviru
mpv
codetect
merscov
occur
bermingham
et
al
drosten
et
al
health
protect
agenc
hpa
uk
novel
coronaviru
investig
team
memish
et
al
includ
virus
often
absent
sampl
posit
merscov
bermingham
et
al
kraaijdirkzwag
et
al
omrani
et
al
found
sampl
neg
merscov
rare
mer
investig
reuss
et
al
test
first
human
case
ksa
use
lrt
sampl
isol
merscov
cultur
conduct
immunofluoresc
virus
neg
ifv
piv
rsv
adv
rtpcr
virus
neg
adv
ev
mpv
hhv
rtpcr
also
detect
merscov
case
export
greec
test
found
neg
ifv
legionella
pneumococcu
bacteri
test
conduct
impact
bacteri
copres
also
unclear
devi
et
al
memish
et
al
tsiodra
et
al
two
mer
case
travel
ksa
netherland
neg
rsv
adv
bocaviru
bov
piv
hcov
hrv
ifv
rsv
mpv
kraaijdirkzwag
et
al
test
respiratori
pathogen
strongli
recommend
world
health
organ
limit
data
address
occurr
coinfect
altern
viral
diagnos
among
case
contact
suspect
merscov
infect
littl
known
caus
merslik
pneumonia
ksa
gener
burden
diseas
due
known
classic
respiratori
virus
includ
endem
human
coronavirus
despit
widespread
use
elucid
role
dc
sourc
merscov
strateg
widespread
serosurvey
conduct
human
use
sampl
collect
develop
robust
serolog
assay
hing
access
reliabl
panel
wellcharacteris
anim
human
sera
includ
posit
antibodi
specif
merscov
like
agent
crossreact
obtain
control
materi
problemat
slow
develop
commerci
assay
human
test
one
compani
produc
elisa
kit
detect
igg
camel
use
recombin
receptorbind
subunit
merscov
protein
antigen
produc
diagnost
reagent
immunofluoresc
euroimmun
medizinisch
labordiagnostika
agf
serosurvey
essenti
determin
baselin
anim
commun
exposur
merscov
among
countri
arabian
peninsula
earli
serosurvey
human
use
convent
immunofluoresc
assay
ifa
antibodi
present
patient
sera
attach
merscov
infect
cell
cultur
identifi
presenc
igg
igm
neutralis
antibodi
corman
et
al
drosten
et
al
zaki
et
al
sign
merscov
antibodi
found
among
sera
patient
visit
dr
soliman
fakeeh
hospit
jeddah
ksa
sign
prior
merscov
infect
found
among
healthi
blood
donor
screen
king
abdulaziz
univers
hospit
jeddah
collect
januari
decemb
eight
slaughterhous
worker
posit
ifa
result
could
confirm
neutral
nt
test
studi
indic
like
sourc
crossreact
antigen
ifa
aburizaiza
et
al
absenc
merscov
antibodi
among
slaughterhous
worker
may
reflect
kill
older
dc
less
often
merscov
posit
see
tabl
rariti
infect
anim
limit
transmiss
risk
associ
slaughter
dc
aburizaiza
et
al
weak
immun
respons
human
get
sever
mer
overal
low
risk
merscov
transmiss
contact
ifa
also
suffer
crossreact
convalesc
sar
patient
sera
could
resolv
nt
test
chan
et
al
need
wellvalid
assay
emphasis
publicli
releas
merscov
antibodi
test
result
indic
handshak
two
facetofac
meet
suffici
merscov
transmiss
two
peopl
usa
cdc
newsroom
sampathkumar
result
subsequ
retract
withstand
confirmatori
analysi
less
rapid
highli
specif
nt
assay
cdc
newsroom
biolog
safe
ifa
develop
requir
infecti
viru
instead
base
transfect
cell
express
recombin
portion
merscov
n
gene
corman
et
al
reuss
et
al
recombin
lentivirus
express
merscov
protein
luciferas
also
safer
simpler
diagnost
altern
work
infecti
merscov
zhao
et
al
pseudo
particl
neutral
ppnt
assay
seen
widespread
use
anim
studi
least
sensit
microneutr
mnt
test
hemida
et
al
hemida
et
al
hemida
et
al
perera
et
al
reusken
et
al
studi
sera
collect
king
fahd
hospit
eastern
region
ksa
children
lrt
infect
may
may
year
old
male
blood
donor
evid
merscov
neutralis
antibodi
could
found
use
ppnt
assay
gierer
et
al
similarli
studi
four
herdsmen
contact
infect
dc
herd
alahsa
eight
peopl
intermitt
contact
herd
veterinari
surgeon
support
staff
expos
herd
three
unprotect
abattoir
worker
alahsa
control
expos
camel
profession
role
none
serolog
evid
past
merscov
infect
use
ppnt
assay
hemida
et
al
merscov
appear
easili
transmit
dc
human
perhap
trigger
detect
immun
respons
mild
diseas
asymptomat
infect
result
studi
case
import
miss
link
interpret
neg
human
serolog
data
jordanian
outbreak
acut
lrt
diseas
hospit
alzarqa
predat
first
ksa
case
mer
retrospect
found
associ
merscov
infect
initi
via
rtrtpcr
subsequ
larger
scale
use
posit
elisa
ifa
mnt
test
hijawi
et
al
payn
et
al
elisa
use
recombin
n
protein
group
betacoronaviru
pipistrellu
batcov
identifi
antibodi
equival
crossreact
merscov
protein
valid
use
sera
includ
peopl
known
previou
sarscov
hrv
hmpv
influenza
infect
protein
microarray
express
protein
subunit
also
valid
wide
use
dc
test
see
tabl
reusken
et
al
human
screen
date
use
immunogen
portion
subunit
specif
viral
antigen
consid
best
approach
produc
reliabl
serolog
assay
detect
merscov
infect
use
elisa
subunit
protein
microarray
reusken
et
al
usual
follow
confirmatori
ifa
andor
plaquereduct
neutral
prnt
test
aburizaiza
et
al
drosten
et
al
reusken
et
al
mnt
test
perera
et
al
reusken
et
al
confirmatori
method
ensur
antibodi
detect
use
subject
screen
method
may
also
employ
spectrum
potenti
crossreact
antigen
abl
specif
neutralis
intend
viru
broadli
reactiv
coronavirus
found
dc
bovin
cov
bcov
human
sarscov
earli
work
identifi
rang
cell
underw
cytopath
chang
infect
merscov
cultur
includ
cell
eckerl
et
al
zaki
et
al
zielecki
et
al
human
tracheobronchi
epithelium
human
primari
renal
epithelium
african
green
monkey
kidney
vero
vero
ifndefici
rhesu
monkey
kidney
human
bronchial
epithelium
merscov
grow
effici
sarscov
primari
bronchial
cell
primari
kidney
cell
eckerl
et
al
cell
cell
line
support
merscov
transcript
includ
muller
et
al
porcin
kidney
cancer
ps
human
kidney
cancer
human
alveolar
adenocarcinoma
bat
kidney
rousettu
aegyptiacu
pipistrellu
pipistrellu
carollia
perspicillata
bat
lung
rhinolophu
landeri
rhilu
myoti
daubentonii
dc
umbil
cord
ttrb
bat
kidney
pipni
host
merscov
replic
detect
rtpcr
goat
also
produc
greatest
amount
viabl
viru
follow
monkey
human
alpaca
bat
cell
merscov
n
protein
produc
rang
infect
mammalian
cell
includ
chan
et
al
c
human
ex
vivo
bronchial
lung
tissu
embryon
foetal
lung
fibroblast
hfl
gastrointestin
liver
kidney
hek
histiocytoma
porcin
kidney
civet
lung
monkey
kidney
vero
vero
cell
line
support
merscov
growth
includ
chan
et
al
muller
et
al
babi
hamster
kidney
bhk
african
green
monkey
kidney
kidney
cell
common
sourc
passag
cell
line
use
virolog
featur
promin
list
merscovpermiss
cell
line
noteworthi
diabet
also
one
underli
diseas
among
two
third
merscov
posit
peopl
renal
damag
featur
among
patient
sever
diseas
assiri
et
al
pseudoviru
express
merscov
protein
use
examin
bind
cellular
receptor
sarscov
angiotensinconvert
enzym
mhv
carcinoembryon
antigenrel
cell
adhes
molecul
express
nonpermiss
cell
enter
cell
indic
receptor
molecul
merscov
express
otherwis
nonpermiss
bhk
cell
sarscov
could
infect
muller
et
al
addit
blockad
antibodi
prevent
sarscov
infect
cell
otherwis
permiss
viru
merscov
could
still
infect
muller
et
al
extract
cell
permiss
merscov
infect
vero
yield
kda
protein
bound
recombin
merscov
protein
domain
identifi
mass
spectrometri
exopeptidas
dipeptidyl
peptidas
also
call
typeii
transmembran
glycoprotein
receptor
ident
confirm
use
solubl
competit
inhibit
merscov
infect
vero
cell
well
transient
express
cell
render
permiss
merscov
memish
et
al
raj
et
al
antibodi
also
block
human
dc
merscov
variant
infect
otherwis
permiss
human
bronchial
epitheli
cell
cell
respect
inhibitor
function
indic
structur
rather
function
import
merscov
attach
rnaposit
cell
detect
rtpcr
deriv
goat
lung
alpaca
kidney
camel
umbil
cord
bat
kidney
human
lung
monkey
kidney
protein
also
found
epitheli
cell
differ
speci
organ
includ
kidney
renal
duct
small
intestin
lung
umbil
cord
liver
prostat
activ
leukocyt
elev
level
solubl
form
blood
allerg
asthma
lun
et
al
raj
et
al
limit
express
found
lung
merscov
nonpermiss
anim
includ
mice
syrian
hamster
present
express
also
seen
ferret
dc
sheep
goat
cow
bronchialbronchiolar
tissu
renal
tubular
tissu
coleman
et
al
van
doremalen
et
al
structur
anim
model
hostbarri
restrict
predict
exist
among
differ
mammal
present
anim
support
merscov
infect
van
doremalen
et
al
human
hamster
exchang
five
key
merscov
sproteininteract
residu
introduc
nonpermiss
bhk
cell
render
permiss
wherea
introduct
human
bhk
cell
success
permit
infect
van
doremalen
et
al
high
affin
merscov
human
similar
anim
molecul
possibl
merscov
detect
human
alreadi
modestli
adapt
human
dc
hors
lesser
extent
goat
consid
sourc
intrus
viru
human
popul
degre
bind
affin
barlan
et
al
raj
et
al
date
sign
natur
merscov
infect
found
goat
sheep
cow
alpaca
despit
small
seropreval
studi
howev
data
suggest
possibl
anim
examin
potenti
anim
host
see
tabl
detail
dc
asthmat
identifi
among
mer
patient
secret
may
decreas
proport
level
cellular
inflamm
molecul
role
tcell
activ
henc
immun
regul
boonack
van
noorden
may
import
asthmat
airway
merscov
infect
studi
look
urt
none
relat
merscov
relev
enzymat
activ
identifi
shown
decreas
nasal
mucosa
patient
rhiniti
inflamm
return
normal
treatment
andor
improv
grouzmann
et
al
date
rbd
merscov
undergon
noteworthi
genet
chang
could
indic
rbd
crucial
factor
speci
adapt
barlan
et
al
time
spent
human
short
see
chang
develop
wide
genet
divers
among
sequenc
differ
anim
speci
strongest
affin
merscov
recombin
protein
close
relat
conserv
among
amino
acid
within
human
sequenc
predict
come
contact
protein
barlan
et
al
autopsi
materi
avail
fatal
mer
case
howev
materi
reflect
mostli
late
stage
diseas
patient
receiv
numer
therapi
spent
time
mechan
ventil
chan
et
al
therefor
diseas
model
system
essenti
studi
pathogenesi
without
confound
influenc
raft
support
medic
procedur
preexist
chronic
diseas
neither
mice
syrian
hamster
support
natur
merscov
replic
coleman
et
al
drosten
get
around
diverg
murin
human
mous
model
construct
introduc
human
gene
adenovir
vector
carri
gene
transduc
cell
mous
airway
result
anim
recept
merscov
infect
day
infect
induc
pneumonia
anim
viral
clearanc
follow
day
infect
model
found
limit
crossprotect
afford
prior
exposur
sarscov
use
model
venezuelan
equin
encephalitisbas
replicon
express
merscov
spike
protein
shown
efficaci
vaccin
candid
produc
protect
immun
respons
subsequ
transgen
mous
model
creat
human
global
express
result
fulli
permiss
model
sever
mer
agraw
et
al
report
mous
model
infect
merscov
close
rel
batcov
note
vaccin
design
emerg
cov
includ
element
particular
viru
sinc
differ
member
genu
insuffici
similar
elicit
immunolog
crossprotect
use
transduc
knockout
mice
reveal
tlrdepend
ifnsignal
pathway
import
control
merscov
replic
preinfect
deliveri
poli
c
speed
clearanc
merscov
infect
mice
effect
poli
c
given
postinfect
given
ribavirin
improv
clinic
statu
virolog
control
macaqu
associ
reduc
system
local
level
proinflammatori
marker
viral
load
tcell
shown
necessari
viru
clearanc
mice
immunodomin
epitop
attract
tcell
respons
present
merscov
protein
mous
model
shown
immunedefici
mice
succumb
sever
diseas
human
comorbid
may
affect
immun
function
date
nontransduc
anim
model
merscov
infect
rhesu
macaqu
monkey
expens
anim
hous
work
multisit
infect
protocol
deliv
tissu
cultur
infecti
dose
tcid
merscov
year
old
macaqu
via
combin
intranas
oral
ocular
intratrach
rout
attempt
recreat
diseas
seen
human
yao
et
al
result
transient
mildtomoder
clinic
diseas
includ
leucocytosi
acut
localisedtowidespread
radiograph
chang
consist
pneumonia
three
day
infect
viral
rna
detect
conjunctiva
nasal
mucosa
also
day
six
tonsil
trachea
bronchu
mediastin
lymph
node
lung
mostli
reduc
level
day
three
dewit
et
al
day
six
viru
mostli
undetect
urt
gener
decreas
quantiti
day
three
highest
load
one
day
inocul
dewit
et
al
much
shorter
found
serial
sampl
human
case
analys
kraaijdirkzwag
et
al
shed
respiratori
tract
continu
day
six
two
three
macaqu
dewit
et
al
level
viral
rna
remain
high
bal
sampl
day
one
three
dewit
et
al
viru
viral
rna
found
kidney
patholog
kidney
chang
kidney
failur
note
among
macaqu
dewit
et
al
yao
et
al
microarray
analysi
merscov
infect
macaqu
sampl
identifi
rapid
innat
immun
activ
increas
express
gene
involv
proinflammatori
process
cell
recruit
includ
interleukin
chemokin
cxc
ligand
matrix
metalloproteinas
dewit
et
al
day
six
post
inocul
gene
express
macaqu
peripher
blood
mononuclear
cell
lung
return
baselin
dewit
et
al
viral
dosag
spread
deliveri
may
unrealist
sinc
learn
much
milder
diseas
uncommon
among
merscovposit
human
especi
younger
underli
comorbid
macaqu
model
fulfil
need
see
purifi
viral
prepar
produc
diseas
akin
seen
among
human
case
direct
lrt
compon
viru
deliveri
model
like
reflect
proport
human
rout
viru
acquisit
notabl
human
diseas
involv
lrt
howev
may
also
bia
studi
potenti
urt
respons
first
contact
viru
host
therefor
overlook
rout
ingress
length
natur
prodrom
merscov
believ
caus
mer
human
causal
extrapol
studi
macaqu
model
merscov
sarscov
compar
use
human
airway
epitheli
hae
cultur
compris
bronchial
epitheli
cell
differenti
air
liquid
interfac
contain
basal
secretori
columnar
ciliat
cell
gener
mucou
kindler
et
al
system
aim
recreat
main
epitheli
line
possibl
site
first
contact
host
merscov
kindler
et
al
pretreat
cultur
interferon
prove
effect
reduc
replic
merscov
sarscov
kindler
et
al
ad
ex
vivo
bronchial
lung
tissu
one
hour
merscov
infect
viru
titr
rna
level
decreas
notic
merscov
sarscov
merscov
also
elicit
compar
poor
proinflammatori
cytokin
respons
extent
pretreat
chan
et
al
merscov
fail
induc
tumour
necrosi
factor
alpha
upregul
regul
activ
normal
tcell
express
secret
rant
mrna
chan
et
al
howev
merscov
perhap
better
replic
tissu
sarscov
target
type
type
ii
alveolar
cell
within
lung
indic
potenti
hinder
lung
regener
infect
sinc
type
ii
cell
import
repair
chan
et
al
comparison
gener
mild
pathogen
replic
lung
tissu
influenza
viru
known
associ
viral
pneumonia
chan
et
al
immunobiolog
analysi
use
cell
line
support
merscov
grow
better
sensit
sarscov
merscov
also
weak
induc
ifn
like
immun
dampen
effect
sarscov
mediat
via
retent
interferon
regulatori
factor
cytoplasm
infect
cell
zielecki
et
al
merscov
shown
sensit
although
base
pretreat
cell
situat
mimic
clinic
realiti
human
case
mer
zielecki
et
al
kindler
et
al
note
compar
limit
transcript
respons
infect
hae
cultur
cov
induct
mild
induct
proinflammatori
cytokin
may
mean
merscov
alreadi
adapt
grow
cell
kindler
et
al
profession
cytokineproduc
cell
plasmacytoid
convent
dendrit
cell
macrophag
lack
hae
system
present
ex
vivo
tissu
cell
need
see
full
extent
immun
respons
cov
kindler
et
al
use
embryon
lung
fibroblast
cell
line
hfl
allow
growth
identifi
induct
merscov
polaris
cell
merscov
sarscov
differ
elicit
cytokin
gene
transcript
lau
et
al
threeway
viru
comparison
merscov
sarscov
cellular
mrna
analys
respons
type
ifn
type
iii
ifn
cov
infect
kindler
et
al
proinflammatori
gene
mrna
protein
level
increas
merscov
infect
compar
sarscov
innat
antivir
gene
protein
compar
decreas
h
postinfect
lau
et
al
apart
reduc
innat
antivir
respons
time
respons
also
differ
merscov
appear
delay
cytokin
induct
merscov
produc
less
h
compar
sarscov
sarscov
also
grew
less
effici
destruct
merscov
cell
primari
bronchial
primari
kidney
cell
took
longer
reach
peak
viral
product
eckerl
et
al
kindler
et
al
growth
merscov
sarscov
also
compar
cell
cultur
includ
primari
undifferenti
human
tracheobronchi
epitheli
cell
htbe
vero
human
embryon
kidney
cell
sarscov
merscov
grew
similar
kinet
cell
zielecki
et
al
josset
et
al
note
merscov
induc
signific
cytopath
chang
accompani
earlier
distinct
chang
global
transcriptom
josset
et
al
fourteenfold
differenti
express
gene
note
merscov
uniqu
downregul
gene
relat
antigen
present
lymphocyt
signal
upregul
relat
campmedi
signal
ubiquitin
josset
et
al
increas
rel
growth
sarscov
cell
compar
use
hae
cultur
might
reflect
latter
variabl
express
sarscov
receptor
josset
et
al
josset
et
al
kindler
et
al
sarscov
merscov
upregul
viral
recognit
innat
immun
pathway
activ
gene
interferon
regulatori
factor
irf
downregul
metabol
gene
josset
et
al
rapid
merscov
host
cell
express
chang
postinfect
treatment
kinas
inhibitor
effect
pretreat
josset
et
al
reinforc
challeng
face
treatment
mer
case
present
diseas
process
well
engag
merscov
shown
infect
replic
within
primari
human
monocytederiv
macrophag
produc
consider
viru
contrast
sarscov
could
enter
propag
within
dendrit
cell
zhou
et
al
interestingli
merscov
antigen
found
colocalis
macrophag
infect
ex
vivo
lung
tissu
chan
et
al
contrast
work
hae
system
dendrit
cell
infect
result
upregul
though
proinflammatori
cytokin
zhou
et
al
also
infect
trigger
significantli
higher
level
rant
equival
dose
sarscov
zhou
et
al
clinic
practic
two
mer
patient
franc
found
differ
respons
faur
et
al
patient
die
mount
robust
type
ifn
respons
patient
surviv
mount
respons
particularli
notabl
patient
absenc
compar
littl
rigi
faur
et
al
promot
antivir
adapt
immun
respons
clear
viru
patient
also
compar
increas
level
immunosuppress
role
sabat
spike
proinflammatori
role
late
cours
diseas
patient
rais
also
proinflammatori
immun
studi
rais
question
whether
age
immun
statu
genet
disord
affect
ifn
signal
product
could
risk
factor
sever
mer
whether
action
merscov
suffici
interfer
signal
anim
sourc
intermedi
host
consid
earli
mer
outbreak
three
first
five
case
contact
dc
albarrak
et
al
prome
reuss
et
al
unclear
time
approxim
merscov
detect
commun
outbreak
hafr
albatin
june
august
possibl
trigger
index
case
dc
contact
memish
et
al
today
anim
merscov
infect
must
report
world
organ
anim
health
oie
emerg
diseas
anim
contact
human
defin
summari
first
mer
case
direct
within
day
prior
symptom
onset
merscov
research
group
definit
made
specif
allow
acquisit
dropletbas
rout
still
assum
common
rout
acquisit
viru
predominantli
caus
respiratori
diseas
assiri
et
al
b
zumla
memish
provid
support
droplet
transmiss
rout
one
report
identifi
viral
rna
air
sampl
collect
barn
hous
infect
dc
azhar
et
al
precis
rout
human
acquir
merscov
remain
unproven
earli
continu
throughout
mer
epidem
ksa
older
human
male
featur
promin
especi
among
index
case
impli
behaviour
factor
may
play
role
penttinen
et
al
factor
may
provid
import
clue
human
case
report
dc
contact
report
contact
infect
human
leav
group
without
obviou
rout
acquisit
fig
whether
definit
anim
contact
suffici
captur
exposur
respiratori
viru
remain
unclear
case
sometim
list
diseas
notic
proxim
camel
farm
individu
may
deni
come
contact
anim
altern
path
acquir
infect
report
mani
instanc
fewer
half
human
case
report
camel
contact
gossner
et
al
constitut
definit
contact
interview
unclear
may
updat
risk
assess
specif
word
focus
consumpt
camel
product
equival
word
use
ascrib
risk
potenti
droplet
rout
acquisit
merscov
dc
exampl
understood
mer
peopl
high
risk
sever
diseas
diabet
renal
failur
chronic
lung
diseas
immunocompromis
person
take
precaut
visit
farm
market
camel
present
precaut
includ
avoid
contact
camel
drink
raw
camel
milk
camel
urin
eat
meat
thoroughli
cook
world
health
organ
despit
earli
evid
dc
contact
divers
coronavirus
known
exist
among
bat
made
wide
discuss
initi
focu
fig
shi
smith
wang
woo
et
al
nonetheless
date
merscovspecif
data
point
bat
origin
amplifi
fragment
rnadepend
rna
polymeras
gene
merscov
genom
identifi
fecal
pellet
insectivor
emballonurida
bat
taphoz
perforatu
commonli
call
egyptian
tomb
bat
bisha
ksa
short
sequenc
fragment
defin
diagnost
discoveri
write
better
sequenc
match
exist
genbank
sequenc
databas
unfortun
sequenc
sampl
could
obtain
cold
chain
broken
sampl
ship
usa
studi
thaw
decay
role
bat
natur
host
merscov
host
merscovlik
viru
remain
proven
dromedari
camel
make
camel
central
presenc
arabian
peninsula
humandc
contact
rang
littl
close
gossner
et
al
mer
camel
densiti
greatest
around
horn
africa
specif
ethiopia
somalia
kenya
sudan
south
sudan
gossner
et
al
near
ksa
yemen
highest
densiti
camel
within
countri
hail
region
dens
popul
dc
gossner
et
al
despit
human
mer
case
region
contact
may
commonplac
could
occur
varieti
way
fig
sever
larg
wellattend
festiv
race
sale
parad
featur
dc
dc
also
kept
bred
close
popul
area
ksa
dc
milk
meat
wide
collect
consum
dc
anim
ritual
signific
hajj
pilgrimag
howev
merscov
infect
frequenc
appear
much
lower
widespread
frequent
habit
eat
drink
prepar
camel
product
daili
ingest
fresh
unpasteuris
dc
milk
common
among
desert
bedouin
mani
other
ksa
apart
nutrit
valu
perceiv
health
benefit
avail
camel
milk
report
adjunct
standard
type
diabet
manag
agraw
et
al
mohamad
et
al
dc
urin
also
consum
use
suppos
health
benefit
includ
belief
keep
hair
parasitefre
report
applic
aspirinlik
antiplateletaggreg
substanc
alhaidar
et
al
specif
anticanc
immun
modul
substanc
alyousef
et
al
august
reusken
et
al
report
first
serosurvey
livestock
live
region
tabl
reusken
et
al
dc
sampl
mostli
canari
islandborn
origin
import
horn
africa
centuri
herd
omani
dc
mostli
import
high
number
high
turnov
africa
retir
race
test
use
protein
microarray
express
portion
receptorbind
subunit
protein
sarscov
merscov
reusken
et
al
c
rang
anim
also
test
nondc
sera
test
neg
merscov
antibodi
neutralis
antibodi
assay
found
strongli
seroposit
canari
island
dc
sera
could
neutralis
viru
omani
dc
sera
high
level
specif
merscov
neutralis
antibodi
reusken
et
al
indic
dc
past
infect
merscov
similar
viru
spread
camel
beyond
border
remain
unclear
sinc
studi
host
peerreview
report
look
dc
anim
possibl
may
play
host
merscov
infect
tabl
seroposit
dc
found
throughout
arabian
peninsula
africa
reusken
et
al
reusken
et
al
anim
test
includ
sheep
cow
pig
hors
bird
water
buffalo
goat
bactrian
camel
llama
guanaco
south
american
camelid
mani
anim
test
small
number
rat
mice
cat
baboon
widerang
saudi
arabia
known
come
contact
human
travel
cave
possibl
frequent
bat
yet
test
alagaili
et
al
alexandersen
et
al
meyer
et
al
perera
et
al
reusken
et
al
c
larg
studi
sera
equid
hors
donkey
mule
uae
spain
none
harbour
sign
neutralis
antibodi
merscov
meyer
et
al
initi
serolog
tool
employ
cautiou
analysi
report
posit
dc
seroposit
merscov
close
relat
viru
alexandersen
et
al
perera
et
al
reusken
et
al
subsequ
diagnost
detect
merscov
rna
recoveri
infecti
viru
occur
dc
sampl
alagaili
et
al
azhar
et
al
chu
et
al
haagman
et
al
hemida
et
al
nowotni
kolodziejek
raj
et
al
full
major
length
genom
merscov
sequenc
haagman
et
al
hemida
et
al
find
confirm
dc
version
merscov
least
similar
genet
phylogent
interleav
variant
detect
differ
human
time
across
distanc
fig
one
anim
taphoz
perforatu
bat
contain
trace
merscov
rna
date
antibodi
screen
assay
sometim
detect
crossreact
antibodi
sera
identifi
screen
sera
like
viral
culprit
exampl
bcov
antigen
facsimil
bcov
possibl
merscovlik
virus
also
resid
within
camel
would
way
detract
current
definit
character
ident
merscov
sequenc
found
camel
camel
screen
studi
shown
juvenil
dc
often
viru
viral
rna
posit
older
dc
like
seroposit
rna
viru
neg
rna
posit
process
seroconvert
indic
recent
infect
hemida
et
al
hemida
et
al
adult
merscov
rna
detect
among
anim
preexist
antibodi
suggest
reinfect
also
possibl
hemida
et
al
viral
load
among
posit
camel
high
alagaili
et
al
hemida
et
al
hemida
et
al
nowotni
kolodziejek
camel
found
posit
ill
urt
respiratori
sign
adney
et
al
azhar
et
al
hemida
et
al
memish
et
al
obvious
unwel
find
indic
camel
host
natur
merscov
infect
furthermor
store
camel
sera
reveal
sign
merscov
camel
date
back
two
decad
alagaili
et
al
alexandersen
et
al
older
sera
test
precis
long
camel
afflict
merscov
whether
viru
enzoot
among
introduc
ago
bat
subject
regular
shortliv
viral
incurs
perhap
occasion
human
yet
answer
next
step
prove
direct
infect
dc
transmit
viru
human
human
infect
camel
qatari
site
farm
owner
employe
becam
ill
midoctob
test
posit
merscov
rna
sputum
throat
swab
sampl
respect
rtrtpcr
found
merscov
rna
posit
camel
nasal
swab
farm
six
met
intern
criteria
posit
two
assay
result
indic
recent
outbreak
occur
herd
first
indic
merscov
rna
found
within
dc
tempor
associ
human
infect
three
posit
dc
sampl
confirm
sequenc
portion
gene
sequenc
ident
close
homolog
human
camel
merscov
sequenc
dc
human
contact
yield
sequenc
differ
singl
nucleotid
cluster
close
hafralbatin
variant
subsequ
anoth
case
studi
found
evid
concurr
human
camel
infect
direct
infect
infer
ill
dc
human
owner
azhar
et
al
drosten
et
al
memish
et
al
partial
genom
sequenc
indic
human
merscov
rtrtpcr
posit
camel
infect
variant
viru
harbour
distinct
pattern
nucleotid
polymorph
memish
et
al
nine
camel
owner
herd
serial
sampl
react
recombin
antigen
elisa
two
anim
rtrtpcr
posit
show
small
verifi
rise
antibodi
titr
memish
et
al
rise
titr
theoret
begin
day
camel
infect
memish
et
al
sampl
author
subsequ
publish
studi
farmer
camel
herd
sampl
collect
day
earlier
suggest
rise
titr
camel
sera
occur
alongsid
declin
rna
load
patient
activ
ill
hospitalis
indic
camel
infect
first
follow
owner
azhar
et
al
memish
et
al
bovin
coronaviru
bcov
antibodi
also
present
rise
one
two
rtrtpcr
posit
anim
anim
antibodi
could
neutralis
bcov
infect
memish
et
al
studi
show
dc
perhap
one
anim
speci
test
reservoir
merscov
seem
often
infect
camel
expos
merscov
way
least
two
decad
remain
unknown
whether
isol
reservoir
would
stop
sporad
transmiss
merscov
human
nishiura
et
al
three
adult
dc
infect
intranas
intrach
conjunctiv
tcid
merscov
studi
unit
state
amount
similar
shed
infect
camel
mild
urt
diseas
mostli
urtlocalis
viru
replic
result
adney
et
al
infecti
viru
also
detect
trachea
one
four
lung
lobe
test
well
retropharyng
mediastin
mesenter
tracheobronchi
lymph
node
urt
shed
infecti
viru
continu
seven
day
inocul
viral
rna
could
detect
day
nasal
swab
small
quantiti
viral
rna
cultur
viru
detect
exhal
breath
viru
viral
rna
detect
serum
whole
blood
viral
rna
could
detect
faec
urin
day
post
inocul
adney
et
al
strong
neutralis
antibodi
respons
produc
camel
day
post
inocul
also
know
whether
camel
essenti
maintain
chain
human
infect
subsequ
amplifi
appar
cluster
outbreak
spread
humantohuman
parturit
dc
occur
winter
month
earli
gregorian
calendar
year
may
driver
subsequ
spike
human
case
seen
memish
et
al
juvenil
camel
appear
host
activ
infect
often
adult
camel
may
help
explain
slaughter
camel
must
five
year
age
older
contribut
significantli
exposur
among
slaughterhous
worker
nowotni
kolodziejek
small
number
test
dc
australia
seroposit
expand
virolog
investig
australian
sourc
export
african
camel
well
bat
may
lead
find
ancestr
viral
variant
seroposit
anim
geograph
area
identifi
anim
sourc
zoonot
spread
import
inform
option
reduc
human
exposur
hemida
et
al
merscov
genom
appear
chang
significantli
movement
human
human
camel
spillov
human
variant
show
littl
diverg
camel
merscov
variant
impli
major
sourc
human
acquisit
camel
rather
anoth
anim
test
anim
speci
need
support
conclus
month
dc
viru
sequenc
differ
occas
chang
genet
indic
high
level
genom
stabil
support
possibl
dc
might
natur
rather
intermedi
host
merscov
know
today
hemida
et
al
precis
role
camel
rout
human
acquisit
merscov
camel
sporad
infect
remain
determin
nonetheless
absenc
like
anim
sourc
interest
public
health
risk
reduct
activ
recommend
reduc
contact
camel
especi
ill
limit
contact
camel
secret
excret
includ
handl
camel
milk
meat
butcher
camel
potenti
aerosolgener
procedur
yet
defin
describ
studi
acknowledg
plain
languag
risk
date
see
section
aerosol
risk
thu
camel
develop
sign
urt
diseas
shed
infecti
viru
high
quantiti
urt
secret
possibl
exist
may
aerosolis
viru
transmiss
merscov
defin
sporad
intrafamili
healthcar
associ
memish
et
al
viru
characteris
role
caus
sever
therefor
obviou
ill
human
earli
sentinel
highlight
incurs
spread
merscov
within
famili
omrani
et
al
peopl
well
document
health
protect
agenc
hpa
uk
novel
coronaviru
investig
team
mer
puzelli
et
al
howev
first
known
mer
outbreak
one
acut
lrt
diseas
healthcar
set
hijawi
et
al
occur
alzarqa
jordan
retrospect
link
merscov
detail
laboratori
epidemiolog
analys
hijawi
et
al
bal
serum
sampl
two
case
found
merscov
rtrtpcr
posit
number
probabl
case
subsequ
ad
outbreak
hijawi
et
al
investig
deploy
elisa
employ
genet
antigen
similar
recombin
nucleocapsid
antigen
chan
et
al
merscov
infect
vero
cell
ifa
mnt
test
found
addit
case
among
sera
subject
serolog
alon
meet
current
definit
case
optimis
thoroughli
valid
seroassay
employ
alongsid
good
clinic
histori
still
identifi
previou
occurr
infect
pcr
test
occas
serolog
usual
find
viral
footprint
absenc
clear
sign
symptom
diseas
knibb
et
al
also
case
molecular
test
care
need
move
newli
develop
diagnost
serolog
algorithm
research
set
one
inform
public
health
decis
cdc
newsroom
time
test
sampl
focuss
collect
patient
sever
ill
milder
acut
respiratori
tract
infect
conduct
prospect
casecontrol
studi
contact
confirm
mer
case
observ
ill
absenc
sign
symptom
sampl
gener
test
laboratori
bias
earli
data
toward
ill
hospitalis
patient
often
describ
tip
iceberg
test
paradigm
chang
increas
test
contact
asymptomat
mild
infect
recognis
rise
proport
asymptomat
case
enlarg
denomin
calcul
proport
fatal
case
dudley
mackay
drop
proport
fatal
case
numer
identifi
septemb
penttinen
et
al
histor
rise
consist
chang
definit
laboratori
clinic
respons
understand
newli
discov
viru
first
note
among
sever
ill
adjust
test
occur
case
milder
diseas
subclin
infect
note
among
merscov
posit
peopl
time
appar
cyclic
pattern
averag
weekli
age
peopl
posit
merscov
fig
howev
age
distribut
chang
notabl
outbreak
shift
toward
younger
peopl
becam
evid
fig
group
hcw
compris
merscov
detect
appar
close
follow
publicli
releas
case
data
weekli
proport
infect
hcw
increas
dramat
alongsid
spike
overal
detect
fig
explain
date
spike
intim
associ
healthcarefacil
relat
outbreak
penttinen
et
al
spike
drive
observ
decreas
averag
age
event
afflict
hcw
well
famili
usual
younger
inpati
mer
healthcar
facil
therefor
regular
target
suggest
improv
aim
bolster
weak
infect
prevent
control
ipc
procedur
penttinen
et
al
world
health
organ
may
publish
guidelin
ipc
care
probabl
confirm
case
merscov
infect
healthcar
set
world
health
organ
outbreak
largest
rapid
accumul
merscov
detect
date
fig
april
greatest
number
merscov
detect
month
record
fig
outbreak
mostli
case
associ
humantohuman
spread
within
hospit
environ
thought
result
lack
breakdown
ipc
brown
zumla
hui
follow
rapid
increas
case
number
rise
fatal
ensu
fig
genom
sequenc
indic
viral
chang
viru
well
characteris
chang
may
flag
alter
transmiss
replic
lethal
respons
drug
genet
sequenc
examin
show
multipl
variant
circul
among
peopl
camel
ksa
comparison
massiv
genom
sequenc
approach
taken
toward
track
ebola
viru
transmiss
evolut
west
africa
chan
et
al
hand
merscov
genom
sequenc
report
major
merscov
detect
date
occur
conclus
variant
divers
extrapol
rel
sequenc
genom
outbreak
indic
outstand
genet
possibl
replic
chang
earlier
variant
world
health
organ
parallel
outbreak
anoth
hcw
cluster
occur
uae
index
case
either
outbreak
acquir
merscov
remain
unknown
genom
sequenc
also
use
defin
boundari
cluster
outbreak
base
similar
variant
present
among
infect
human
anim
differ
healthcar
facil
fig
cotten
et
al
approach
clearli
seen
defin
geograph
constrain
hospit
mer
outbreak
alahsa
occur
april
may
well
cluster
buraidah
commun
outbreak
hafr
albatin
ksa
cotton
et
al
employ
molecular
epidemiolog
found
sign
transmiss
chain
extend
beyond
two
three
month
extens
opportun
viru
adapt
human
sustain
serial
transmiss
infrequ
cotten
et
al
sequenc
merscov
genom
alahsa
hospit
outbreak
indic
multipl
viral
variant
contribut
case
similar
enough
consist
humantohuman
transmiss
assiri
et
al
b
cotten
et
al
contact
trace
describ
detail
mer
case
export
beyond
middl
east
trace
usual
identifi
dozen
potenti
case
per
confirm
case
time
consum
expens
process
essenti
understand
transmiss
contain
viru
littl
known
eightythre
symptomat
asymptomat
contact
case
import
germani
unit
arab
emir
uae
harbour
sign
viru
antibodi
reuss
et
al
similar
exampl
limit
onward
transmiss
hallmark
contact
trace
result
date
studi
contact
case
import
franc
seven
match
definit
possibl
case
test
one
share
room
bed
apart
index
case
posit
determin
nosocomi
acquisit
maill
et
al
possibl
mild
yet
posit
case
may
identifi
contact
test
regardless
symptom
contact
first
two
mer
case
import
usa
test
posit
bialek
et
al
none
among
contact
two
case
import
netherland
develop
merscov
antibodi
kraaijdirkzwag
et
al
apart
clearli
defin
case
studi
nosocomi
infect
nosocomi
spread
also
suspect
among
number
mer
case
note
analysi
public
data
author
observ
case
admit
hospit
support
nonrespiratori
medic
condit
develop
respiratori
symptom
test
posit
merscov
within
incub
period
merscov
infect
one
exampl
identifi
like
role
mild
asymptomat
case
present
hospit
admiss
reason
likeliest
index
case
famili
cluster
omrani
et
al
studi
valid
laboratori
test
mild
case
accompani
process
restrict
exposur
other
especi
older
famili
member
friend
underli
diseas
merscov
infect
person
infecti
merscov
ad
camel
goat
cow
milk
store
c
could
recov
least
h
later
c
h
afterward
van
doremalen
et
al
keep
capabl
retain
viabil
water
day
predict
day
depend
type
water
temperatur
gundi
et
al
merscov
titr
decreas
somewhat
recov
milk
c
pasteur
ablat
merscov
infect
van
doremalen
et
al
subsequ
studi
merscov
rna
identifi
milk
nasal
secret
faec
camel
qatar
plastic
steel
surfac
inocul
tcid
merscov
c
rel
humid
rh
viru
recoveri
attempt
cell
cultur
van
doremalen
et
al
c
rh
merscov
remain
viabl
h
h
c
rh
van
doremalen
et
al
comparison
influenza
viru
could
recov
madindarbi
canin
kidney
mdck
cell
beyond
h
condit
van
doremalen
et
al
aerosol
experi
found
merscov
viabil
decreas
rh
decreas
rh
aerosol
gener
c
influenza
viru
decreas
respect
van
doremalen
et
al
merscov
surviv
inferior
previous
demonstr
sarscov
chan
et
al
howev
context
pathogen
bacteria
remain
viabl
min
cough
aerosol
spread
thu
merscov
abil
remain
viabl
long
time
period
give
capac
thoroughli
contamin
room
occupi
infect
symptomat
patient
knibb
et
al
find
expand
understand
risk
associ
bioaerosol
transmiss
respiratori
virus
mani
set
includ
hospit
wait
room
emerg
depart
treatment
room
open
intens
care
facil
privat
patient
room
natur
qualiti
air
exchang
circul
filtrat
import
variabl
risk
measur
reduct
droplet
spread
human
consid
mechan
humantohuman
transmiss
need
droplet
precaut
emphasis
alahsa
hospit
outbreak
assiri
et
al
b
zumla
memish
extrapol
aerosolgener
event
involv
camel
urin
defec
process
prepar
consumpt
camel
product
factor
risk
measur
reduct
effort
need
defin
whether
stringent
level
person
protect
equip
worn
hcw
anim
handler
remain
prioriti
merscov
detect
talli
sat
analys
basic
reproduct
number
r
averag
number
infect
caus
one
infect
individu
fulli
suscept
popul
return
valu
indic
pandem
like
bauch
orabi
breban
et
al
cauchemez
et
al
poletto
et
al
data
correct
observ
bia
conclus
maintain
chowel
et
al
analys
reflect
chart
small
public
data
sourc
indic
case
could
climb
suddenli
alahsa
outbreak
climb
logarithm
method
use
studi
vari
make
allow
extens
case
number
may
publicli
report
cauchemez
et
al
poletto
et
al
r
greater
sustain
case
climb
would
expect
impact
incomplet
case
contact
trace
limit
commun
test
clinic
defin
case
absenc
laboratori
confirm
might
affect
r
calcul
make
difficult
identifi
pattern
among
case
occurr
implic
posit
among
popul
group
could
occur
thu
greater
transmiss
effici
higher
r
valu
may
possibl
narrow
analysi
index
case
case
earliest
onset
date
cluster
infer
secondari
case
number
one
studi
predict
r
could
slightli
upper
bound
depend
method
use
cauchemez
et
al
studi
hypothesis
high
proport
infect
detect
cauchemez
et
al
similar
analys
await
follow
outbreak
case
mer
result
humantohuman
transmiss
howev
transmiss
ineffici
memish
et
al
omrani
et
al
defin
sporad
rather
sustain
fig
base
observ
studi
human
spread
requir
close
contact
occur
relev
data
scant
appear
major
human
case
merscov
transmit
one
human
date
localis
epidem
merscov
selfsustain
poletto
et
al
index
sporad
case
age
sex
outbreak
arbitrarili
defin
span
week
begin
march
end
week
juli
data
base
laboratori
confirm
case
collat
author
curat
line
list
januari
note
chang
xaxi
scale
bc
defg
sourc
public
data
includ
world
health
organ
ministri
health
flutrack
ministri
health
saudi
arabia
earlier
subsequ
version
chart
maintain
person
websit
mackay
blog
mackay
mackay
blog
mackay
older
yet
establish
whether
infect
thought
acquir
anim
sourc
produc
sever
outcom
spread
human
merscov
research
group
strateg
seroassay
yet
investig
extent
milder
asymptomat
case
contribut
merscov
transmiss
chain
household
studi
contact
merscov
posit
index
patient
rna
antibodi
posit
specif
drug
vaccin
current
avail
treat
infect
merscov
context
still
vaccin
avail
sar
mostli
attribut
breviti
sarscov
global
emerg
imposs
predict
whether
merscov
vaccin
human
use
fall
victim
lack
commerci
interest
remain
relev
time
take
develop
howev
vaccin
use
camel
practic
option
given
ident
share
human
camel
viral
variant
appar
rariti
merscov
spillov
human
appli
young
camel
ahead
first
viru
acquisit
vaccin
may
capabl
erad
merscov
herd
sourc
camel
infect
bat
newli
import
camel
herd
vaccin
would
need
use
ongo
manner
abl
reach
feral
camel
herd
well
care
hospitalis
patient
remain
support
vigil
complic
merscov
research
group
empir
use
antimicrobi
agent
improv
sever
diseas
high
dose
steroid
succeed
revers
progress
respiratori
diseas
merscov
research
group
develop
registr
drug
human
use
suitabl
rapid
use
effect
emerg
infecti
agent
de
wild
et
al
dyall
et
al
howev
research
advanc
area
made
test
formul
previous
approv
food
drug
agenc
fda
usa
smallmolecul
inhibitor
lead
versu
emerg
neglect
rna
virus
silver
project
describ
four
exist
compound
chloroquin
chlorpromazin
loperamid
lopinavir
inhibit
merscov
sarscov
replic
cell
cultur
de
wild
et
al
silver
consortium
anoth
studi
drug
abil
impart
inhibit
upon
merscov
growth
cultur
describ
candid
futur
clinic
mer
intervent
studi
dyall
et
al
also
identifi
follow
investig
preexist
fdaapprov
clinic
drug
encompass
differ
class
therapeut
dyall
et
al
novel
molecul
show
promis
directli
exampl
possibl
target
specif
disrupt
conserv
viral
replic
process
doubl
membran
vesicleassoci
rna
replic
without
caus
cellular
toxic
lundin
et
al
anoth
approach
target
interfac
merscov
rbd
receptor
employ
competit
substrat
inhibitor
enzymat
function
kawalec
et
al
inhibitor
role
antidiabet
drug
alreadi
exist
toler
associ
advers
event
kawalec
et
al
although
unclear
whether
may
alreadi
use
among
mer
patient
underli
kidney
diseas
addit
target
viral
merscov
proteas
import
replicas
polyprotein
matur
may
viabl
strategi
futur
far
remain
conserv
cotten
et
al
compani
novavax
produc
experiment
recombin
nanoparticl
vaccin
candid
base
merscov
protein
gener
import
antimerscov
antibodi
mous
model
coleman
et
al
monoclon
antibodi
eg
direct
toward
protein
capabl
neutralis
infect
merscov
hold
futur
promis
use
therapeut
prophylact
tang
et
al
replicationcompet
propagationdefici
e
genedelet
mutant
merscov
variant
rmerscov
may
also
prove
use
vaccin
candid
truncat
rbd
merscov
shown
elicit
antibodi
mice
et
al
du
et
al
conserv
peptid
rdrp
hcov
also
identifi
may
provid
basi
epitopedirect
univers
vaccin
sharmin
islam
ifn
treatment
shown
promis
culturebas
experi
mer
macaqu
earli
applic
requir
effect
macaqu
infect
tcid
merscov
h
infect
treat
substanti
amount
subcutan
along
intraven
ribavirin
follow
ribavirin
dose
intramuscularli
everi
h
everi
h
h
infect
treatment
prevent
sign
increas
respir
leucocytosi
neutrophilia
reduct
oxygen
satur
seen
untreat
anim
plu
treat
macaqu
littl
radiograph
evid
pneumonia
viral
load
daili
bal
differ
treat
untreat
macaqu
load
reduc
treat
anim
postmortem
tissu
fewer
tissu
merscov
rtpcr
posit
sinc
mer
seem
prolong
diseas
well
engag
mackay
blog
mackay
upon
present
medic
help
unclear
drug
cocktail
could
deliv
earli
enough
moder
sever
diseas
triall
five
critic
ill
patient
comorbid
median
time
hospit
treatment
day
rang
day
respons
treatment
evid
use
primari
treatment
infect
physician
prophylaxi
wife
unclear
whether
cocktail
effect
khalid
et
al
took
lead
collat
data
provid
offici
voic
emerg
mer
septemb
hartl
world
health
organ
global
alert
respons
gar
diseas
outbreak
news
releas
kept
world
updat
detail
deidentifi
case
inform
provid
soon
forward
countri
ministri
health
equival
per
transpar
requir
intern
health
regul
ihr
howev
often
delay
post
inform
notabl
outbreak
new
case
detail
confirm
origin
ksa
six
week
case
announc
via
ksa
ministri
health
websit
often
data
inconsist
includ
error
format
variat
often
lack
key
inform
includ
date
present
death
insuffici
inform
permit
linkag
announc
case
one
hundr
case
remain
devoid
key
data
exclud
epidemiolog
analys
particular
problem
period
rapid
case
accumul
becam
concern
global
commun
avail
don
fill
vital
miss
detail
addit
import
demograph
data
like
age
sex
essenti
date
permit
improv
understand
ill
onset
occur
case
hospitalis
whether
asymptomat
newli
announc
case
contact
anoth
case
anim
anim
product
howev
don
effect
underli
data
forward
comprehens
data
permit
calcul
instanc
like
laboratori
turnaround
time
possibl
nosocomi
spread
occur
locat
case
determin
factor
whether
cluster
becom
outbreak
local
epidem
data
view
public
also
reli
upon
member
state
epidemiolog
analyst
expert
report
mani
level
health
manag
govern
seek
understand
threat
popul
make
inform
judgement
decis
follow
may
includ
need
rais
alert
level
prepar
laboratori
capac
creat
educ
materi
free
specif
respons
fund
ramp
messag
manag
alter
border
control
issu
travel
alert
activ
essenti
global
prepared
mer
rapidli
comprehens
adopt
updat
publicli
promot
diagnost
tool
test
algorithm
case
definit
guidelin
investig
research
studi
protocol
ipc
guidanc
travel
advic
risk
assess
summari
updat
via
purposebuilt
coronavirusfocuss
websit
social
media
unit
strove
answer
question
pose
everyon
anyon
twitter
turn
allow
user
take
control
dissemin
inform
found
interest
inform
relev
concern
other
social
network
process
also
inform
public
health
bodi
seek
provid
client
detail
desir
role
nexu
collabor
laid
groundwork
accumul
advanc
knowledg
mer
merscov
format
report
ihr
emerg
committe
concern
merscov
role
advis
directorgener
need
action
yet
public
health
emerg
intern
concern
pheic
declar
ihr
emerg
committe
met
eight
time
date
upon
request
also
sent
risk
assess
team
region
gaug
mer
situat
gregori
coordin
depart
commun
note
answer
public
health
expert
provid
greater
public
trust
institut
viru
becom
easili
transmiss
human
caus
widespread
morbid
mortal
hartl
comment
appli
equal
well
emerg
infecti
diseas
comparison
offici
within
ksa
wide
regularli
criticis
move
slowli
shun
collabor
fail
show
proactiv
action
commenc
local
research
mer
merscov
editori
holm
kupferschmidt
reuter
world
health
organ
despit
data
scientif
literatur
strongli
indic
camel
harbour
merscov
close
relat
viru
commun
camel
pose
risk
human
zoonot
sourc
infect
becam
mainstream
public
health
messag
late
april
two
year
discoveri
viru
shift
correl
chang
ksa
minist
health
request
help
contain
outbreak
new
risk
assess
includ
mention
camel
world
health
organ
shortli
thereaft
ksa
deputi
minist
public
health
lead
author
peerreview
merscov
research
professor
ziad
memish
also
ask
step
howev
messag
date
underpin
pauciti
understand
viru
transmit
may
yet
captur
adequ
commun
risk
much
consid
social
media
volatil
resourc
yet
valuabl
one
understand
volatil
nonpeer
review
medium
also
percept
social
media
place
selfi
scienc
tweet
disappear
search
short
period
blog
page
come
go
untrac
alter
onlin
mainstream
news
stori
countri
other
may
suffer
similar
fate
rapidli
becom
old
news
despit
internetdriven
inform
play
vital
role
rapidli
track
unearth
case
cluster
outbreak
diseas
recent
year
case
mer
global
stage
mani
follow
infecti
diseas
cluster
outbreak
pandem
social
media
well
inform
exposur
distil
recent
event
report
commentari
news
stori
world
profession
use
commun
medium
clearli
appreci
fund
stakehold
public
social
media
blog
commun
much
broader
audienc
usual
reach
tradit
scientif
literatur
access
local
global
commun
contribut
fund
research
dearli
seek
sometim
form
mass
commun
use
seek
inform
diseas
outbreak
countri
sometim
entir
mislead
public
audienc
may
spend
time
mostli
background
expertis
interpret
dens
present
often
slow
appear
scientif
public
health
literatur
space
scientif
literatur
mainstream
media
occupi
scienc
commun
may
sometim
sometim
without
relev
scientif
train
uptod
topic
best
academ
epidemiologist
presid
john
f
kennedi
quot
one
person
make
differ
everyon
tri
seem
apt
one
describ
dedic
peopl
often
without
paid
incent
devot
person
time
effort
money
better
understand
commun
infecti
diseas
frequent
updat
data
repositori
small
flutrack
group
constantli
compil
activ
curat
condens
worldwid
news
sourc
thread
inform
often
assembl
pattern
predict
emerg
infecti
diseas
event
well
reach
mainstream
media
line
list
merscov
detect
ministri
health
saudi
arabia
cornerston
case
number
detail
clariti
crawford
kilian
blog
kilian
outstrip
name
provid
link
reliabl
sourc
well
excerpt
highli
eloqu
thoughtprovok
commentari
rang
microbi
infecti
diseas
stori
merscov
one
michael
coston
avian
flu
diari
coston
also
focuss
comment
emerg
infecti
diseas
augment
astut
experienc
public
health
commentari
resourc
larg
inventori
past
post
use
good
effect
creat
new
inform
one
programm
monitor
emerg
diseas
prome
internetbas
report
system
maintain
panel
authorit
profession
rapporteur
prepar
daili
digest
latest
infecti
diseas
happen
freeli
circul
use
wide
read
email
program
monitor
emerg
diseas
workforceori
view
mer
infecti
diseas
shane
granger
random
analyt
provid
excel
perspect
less
frequent
discuss
impact
infecti
diseas
human
granger
blog
virolog
seek
distil
complex
virologyrel
happen
present
data
emerg
viral
diseas
graphic
access
open
access
way
mackay
mackay
maia
majumd
appli
engin
system
expertis
epidemiolog
diseas
majumd
resourc
part
interconnect
web
sourc
contact
person
experi
exist
internet
chase
track
emerg
merscov
doggedli
profession
scienc
writer
resourc
distinct
yet
complimentari
sourc
inform
togeth
sometim
refer
flublogia
often
overlook
perhap
underestim
profession
scientist
clinician
flublogia
compil
use
publicli
avail
deidentifi
data
add
publicli
relev
interpret
greatli
appreci
much
wide
read
far
far
often
cite
anyth
seen
profession
scientif
literatur
also
factual
sourc
inform
salath
et
al
merscov
appear
entrench
camel
viru
infect
urt
may
origin
among
bat
human
infect
may
result
rare
zoonot
spillov
human
mani
potenti
anim
human
environment
sourc
await
test
thank
quick
action
sensit
rapid
molecular
diagnost
tool
requir
achiev
goal
place
avail
sinc
viru
made
known
public
serolog
tool
research
applic
much
slower
start
emerg
robust
valid
readi
wider
use
care
commerci
unavail
remain
issu
widespread
use
collabor
relev
research
group
must
immedi
option
futur
studi
merscov
spread
humantohuman
seem
sporad
sustain
chain
transmiss
evid
date
also
evid
merscov
viru
pandem
concern
despit
mani
opportun
becom
vigil
key
viru
genet
makeup
observ
three
year
known
infect
third
die
central
futur
vigil
continu
screen
sequenc
analysi
time
data
share
whole
genom
sequenc
use
extens
studi
merscov
remain
tool
expert
collabor
key
less
equip
experienc
research
decod
merscov
move
peopl
time
across
distanc
ksa
beyond
border
recent
describ
routin
genotyp
target
equival
inform
also
aid
vigil
nonetheless
figur
model
effici
transmiss
need
confirm
better
serolog
rtrtpcrbase
studi
human
cover
commun
conduct
becom
clear
merscov
may
spread
poorli
humantohuman
spread
effect
around
hospit
environ
indic
trace
back
poor
ipc
practic
protocol
brown
editori
zumla
hui
viru
greatest
impact
underli
diseas
case
sometim
suffer
multipl
comorbid
like
visit
hospit
treatment
creat
perfect
storm
exposur
transmiss
mortal
educ
programm
import
tool
combat
spread
merscov
mer
sar
similar
also
diverg
significantli
characterist
includ
higher
pfc
among
mer
case
current
well
sar
associ
fatal
diseas
older
male
underli
comorbid
broad
tropism
merscov
rapid
vitro
growth
rapid
induct
cytopathogen
chang
robust
yet
distinct
transcript
respons
use
differ
receptor
induct
proinflammatori
reduc
delay
innat
antivir
respons
sensit
extern
signal
differ
sarscov
degre
mer
littl
direct
impact
popul
outsid
arabian
peninsula
rel
case
acquir
outsid
ksa
date
studi
conduct
thu
far
screen
peopl
beyond
sever
ill
appear
preval
merscov
ksa
chanc
secondari
transmiss
within
household
despit
two
mass
gather
afford
viru
mani
million
opportun
spread
remark
report
outbreak
mer
merscov
immedi
event
nonetheless
hospit
across
ksa
continu
describ
mer
case
countri
experienc
mer
rest
world
remain
alert
import
case
especi
mass
gather
event
includ
umrah
ramadan
hajj
pilgrimag
much
remain
unknown
merscov
mer
cooper
datashar
research
need
address
question
includ
natur
host
merscov
camel
sourc
sporad
human
infect
merscov
seropreval
among
human
work
close
camel
low
rout
transmiss
human
human
best
person
protect
equip
adopt
frontlin
hcw
hospit
ipc
measur
insuffici
insuffici
employ
halt
transmiss
merscov
extent
transmiss
clinic
impact
nosocomi
infect
cooccur
respiratori
virus
set
ksa
male
often
afflict
femal
differ
activ
exposur
could
explain
preval
underli
diseas
sex
merscov
infect
gener
result
subclin
outcom
except
comorbid
current
serolog
tool
sensit
detect
immun
respons
mild
subclin
asymptomat
merscov
infect
might
merscov
rare
season
endem
infect
human
like
hcov
long
averag
period
merscov
shed
continu
infect
human
differ
age
sex
vocat
march
april
seem
human
outbreak
mer
beginwhat
event
occur
around
time
year
may
increas
human
exposur
merscov
merscov
continu
affect
wide
area
ksa
low
numbersi
asyetunidentifi
role
mass
gather
viru
acquisit
subsequ
geograph
dissemin
proport
acut
respiratori
tract
diseas
case
continu
go
untest
manifest
sever
diseas
could
clarifi
gap
transmiss
chain
case
case
mer
go
undiagnos
among
peopl
african
countri
known
host
seroposit
virusposit
camel
diverg
merscov
variant
viral
clade
found
camel
human
bat
beyond
arabian
peninsula
localis
merscov
epidem
remind
us
import
commun
level
perhap
need
rethink
stakehold
inform
progress
chase
studi
new
diseas
threat
may
two
case
merscov
import
usa
third
person
propos
first
local
transmiss
event
subsequ
declar
falseposit
case
serv
excel
exampl
gumsho
epidemiolog
work
alongsid
excel
public
commun
comprehens
laboratori
support
wellprepar
clinic
capac
social
mainstream
media
press
confer
comprehens
inform
public
extens
find
gener
expert
health
care
support
laboratori
analysi
yet
lesson
still
learn
balanc
realtim
transpar
need
suitabl
laboratori
confirm
result
case
highlight
effect
social
media
commun
digest
inform
expect
stakehold
compar
use
gener
slower
elit
peerreview
scientif
public
pipelin
often
better
suit
detail
research
descript
long
haul
except
process
unsuit
inform
concern
global
alwaysonlin
public
potenti
threat
immedi
health
provid
context
threat
howev
merscov
rapidli
spread
global
contagion
may
evolv
becom
anoth
may
emerg
futur
vigil
rapid
commun
key
time
respons
earli
contain
everi
time
new
viru
emerg
learn
requir
us
reexamin
previous
knew
one
constant
howev
human
fan
flame
diseas
cluster
becom
outbreak
epidem
pandem
virus
emerg
gain
foothold
without
aid
laps
vigil
mer
highlight
paradigm
stumbl
block
seek
commun
knowledg
contain
understand
spread
natur
viru
also
serv
yet
anoth
remind
us
global
human
anim
health
polit
agricultur
economi
intim
interwoven
take
singl
tini
viru
tip
fine
balanc
